Clinical investigator indicted for fraud in pharmaceutical trials of blockbuster drug
NEW ORLEANS — Dr. Maria Carmen Palazzo was indicted by a federal grand jury on 55 counts of health care fraud and false documentation in…
Read More »Pharma 101 – Pharmaceutical Fraud
Pharmaceutical Fraud News & Insight form the Qui Tam and False Claims Act Perspective
Contact FormTag Archives: Drug Safety
Guess What Else is NOT a Top Priority of the FDA?
Answer: Monitoring postmarketing study commitments. The FDA lacks an effective system for monitoring postmarketing study commitments. See the latest OIG Report, dated June 2006.
Read More »